img

Global Precision Cancer Medicine Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Precision Cancer Medicine Market Insights, Forecast to 2034

Precision cancer medicines, are medications designed to specifically target the unique genetic or molecular characteristics of an individual patient's cancer. These drugs are a central component of personalized cancer medicine and are chosen based on the genomic and molecular profiling of the patient's tumor.
Market Analysis and InsightsGlobal Precision Cancer Medicine Market
Global Precision Cancer Medicine market is expected to reach to US$ 172950 million in 2024, with a positive growth of %, compared with US$ 161690 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Precision Cancer Medicine industry is evaluated to reach US$ 350430 million in 2029. The CAGR will be 12.5% during 2024 to 2029.
Precision cancer medicine, also known as personalized or targeted cancer therapy, is driven by the growing understanding of cancer's molecular and genetic complexity. Advances in genomics and biomarker identification have enabled the development of therapies tailored to an individual's specific cancer characteristics. This approach offers the potential for more effective treatments with fewer side effects compared to traditional chemotherapy. The market benefits from increasing research in oncology, the rise of precision diagnostics, and the growing availability of targeted therapies. However, challenges include the high cost of genetic testing and targeted treatments, as well as the need for comprehensive molecular profiling. Additionally, regulatory approvals and insurance coverage for these therapies can be complex. To maximize the potential of precision cancer medicine, stakeholders must address these challenges, improve accessibility, and continue research into novel biomarkers and therapies to provide tailored cancer care for patients.
Report Covers
This report presents an overview of global Precision Cancer Medicine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Precision Cancer Medicine market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


AbbVie
Johnson & Johnson
Novartis
Gilead Sciences
Roche
Bristol-Myers Squibb
Amgen
AstraZeneca
Merck & Co
Takeda
Merck KGaA
Seagen
Eli Lilly
Ono Pharmaceutical
Pfizer
GSK
Exelixis
Regeneron
Innovent
Hengrui Medicine
Segment by Type
Cancer Immunotherapy
Targeted Therapy

Segment by Application


Lung Cancer
Breast Cancer
Prostate Cancer
Blood-related Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Precision Cancer Medicine introduction, etc. Precision Cancer Medicine Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Precision Cancer Medicine
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Cancer Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Cancer Immunotherapy
1.2.3 Targeted Therapy
1.3 Market by Application
1.3.1 Global Precision Cancer Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Prostate Cancer
1.3.5 Blood-related Cancer
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Cancer Medicine Market Perspective (2018-2029)
2.2 Global Precision Cancer Medicine Growth Trends by Region
2.2.1 Precision Cancer Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Precision Cancer Medicine Historic Market Size by Region (2018-2024)
2.2.3 Precision Cancer Medicine Forecasted Market Size by Region (2024-2029)
2.3 Precision Cancer Medicine Market Dynamics
2.3.1 Precision Cancer Medicine Industry Trends
2.3.2 Precision Cancer Medicine Market Drivers
2.3.3 Precision Cancer Medicine Market Challenges
2.3.4 Precision Cancer Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Precision Cancer Medicine by Players
3.1.1 Global Precision Cancer Medicine Revenue by Players (2018-2024)
3.1.2 Global Precision Cancer Medicine Revenue Market Share by Players (2018-2024)
3.2 Global Precision Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Precision Cancer Medicine, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Precision Cancer Medicine Market Concentration Ratio
3.4.1 Global Precision Cancer Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Medicine Revenue in 2022
3.5 Global Key Players of Precision Cancer Medicine Head office and Area Served
3.6 Global Key Players of Precision Cancer Medicine, Product and Application
3.7 Global Key Players of Precision Cancer Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Cancer Medicine Breakdown Data by Type
4.1 Global Precision Cancer Medicine Historic Market Size by Type (2018-2024)
4.2 Global Precision Cancer Medicine Forecasted Market Size by Type (2024-2029)
5 Precision Cancer Medicine Breakdown Data by Application
5.1 Global Precision Cancer Medicine Historic Market Size by Application (2018-2024)
5.2 Global Precision Cancer Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Precision Cancer Medicine Market Size (2018-2029)
6.2 North America Precision Cancer Medicine Market Size by Type
6.2.1 North America Precision Cancer Medicine Market Size by Type (2018-2024)
6.2.2 North America Precision Cancer Medicine Market Size by Type (2024-2029)
6.2.3 North America Precision Cancer Medicine Market Share by Type (2018-2029)
6.3 North America Precision Cancer Medicine Market Size by Application
6.3.1 North America Precision Cancer Medicine Market Size by Application (2018-2024)
6.3.2 North America Precision Cancer Medicine Market Size by Application (2024-2029)
6.3.3 North America Precision Cancer Medicine Market Share by Application (2018-2029)
6.4 North America Precision Cancer Medicine Market Size by Country
6.4.1 North America Precision Cancer Medicine Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Precision Cancer Medicine Market Size by Country (2018-2024)
6.4.3 North America Precision Cancer Medicine Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Precision Cancer Medicine Market Size (2018-2029)
7.2 Europe Precision Cancer Medicine Market Size by Type
7.2.1 Europe Precision Cancer Medicine Market Size by Type (2018-2024)
7.2.2 Europe Precision Cancer Medicine Market Size by Type (2024-2029)
7.2.3 Europe Precision Cancer Medicine Market Share by Type (2018-2029)
7.3 Europe Precision Cancer Medicine Market Size by Application
7.3.1 Europe Precision Cancer Medicine Market Size by Application (2018-2024)
7.3.2 Europe Precision Cancer Medicine Market Size by Application (2024-2029)
7.3.3 Europe Precision Cancer Medicine Market Share by Application (2018-2029)
7.4 Europe Precision Cancer Medicine Market Size by Country
7.4.1 Europe Precision Cancer Medicine Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Precision Cancer Medicine Market Size by Country (2018-2024)
7.4.3 Europe Precision Cancer Medicine Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Precision Cancer Medicine Market Size (2018-2029)
8.2 China Precision Cancer Medicine Market Size by Type
8.2.1 China Precision Cancer Medicine Market Size by Type (2018-2024)
8.2.2 China Precision Cancer Medicine Market Size by Type (2024-2029)
8.2.3 China Precision Cancer Medicine Market Share by Type (2018-2029)
8.3 China Precision Cancer Medicine Market Size by Application
8.3.1 China Precision Cancer Medicine Market Size by Application (2018-2024)
8.3.2 China Precision Cancer Medicine Market Size by Application (2024-2029)
8.3.3 China Precision Cancer Medicine Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Precision Cancer Medicine Market Size (2018-2029)
9.2 Asia Precision Cancer Medicine Market Size by Type
9.2.1 Asia Precision Cancer Medicine Market Size by Type (2018-2024)
9.2.2 Asia Precision Cancer Medicine Market Size by Type (2024-2029)
9.2.3 Asia Precision Cancer Medicine Market Share by Type (2018-2029)
9.3 Asia Precision Cancer Medicine Market Size by Application
9.3.1 Asia Precision Cancer Medicine Market Size by Application (2018-2024)
9.3.2 Asia Precision Cancer Medicine Market Size by Application (2024-2029)
9.3.3 Asia Precision Cancer Medicine Market Share by Application (2018-2029)
9.4 Asia Precision Cancer Medicine Market Size by Region
9.4.1 Asia Precision Cancer Medicine Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Precision Cancer Medicine Market Size by Region (2018-2024)
9.4.3 Asia Precision Cancer Medicine Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Precision Cancer Medicine Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Precision Cancer Medicine Market Size by Type
10.2.1 Middle East, Africa, and Latin America Precision Cancer Medicine Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Precision Cancer Medicine Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Precision Cancer Medicine Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Precision Cancer Medicine Market Size by Application
10.3.1 Middle East, Africa, and Latin America Precision Cancer Medicine Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Precision Cancer Medicine Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Precision Cancer Medicine Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Precision Cancer Medicine Market Size by Country
10.4.1 Middle East, Africa, and Latin America Precision Cancer Medicine Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Precision Cancer Medicine Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Precision Cancer Medicine Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Precision Cancer Medicine Introduction
11.1.4 AbbVie Revenue in Precision Cancer Medicine Business (2018-2024)
11.1.5 AbbVie Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Precision Cancer Medicine Introduction
11.2.4 Johnson & Johnson Revenue in Precision Cancer Medicine Business (2018-2024)
11.2.5 Johnson & Johnson Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Precision Cancer Medicine Introduction
11.3.4 Novartis Revenue in Precision Cancer Medicine Business (2018-2024)
11.3.5 Novartis Recent Developments
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Details
11.4.2 Gilead Sciences Business Overview
11.4.3 Gilead Sciences Precision Cancer Medicine Introduction
11.4.4 Gilead Sciences Revenue in Precision Cancer Medicine Business (2018-2024)
11.4.5 Gilead Sciences Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Precision Cancer Medicine Introduction
11.5.4 Roche Revenue in Precision Cancer Medicine Business (2018-2024)
11.5.5 Roche Recent Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Precision Cancer Medicine Introduction
11.6.4 Bristol-Myers Squibb Revenue in Precision Cancer Medicine Business (2018-2024)
11.6.5 Bristol-Myers Squibb Recent Developments
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Precision Cancer Medicine Introduction
11.7.4 Amgen Revenue in Precision Cancer Medicine Business (2018-2024)
11.7.5 Amgen Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Precision Cancer Medicine Introduction
11.8.4 AstraZeneca Revenue in Precision Cancer Medicine Business (2018-2024)
11.8.5 AstraZeneca Recent Developments
11.9 Merck & Co
11.9.1 Merck & Co Company Details
11.9.2 Merck & Co Business Overview
11.9.3 Merck & Co Precision Cancer Medicine Introduction
11.9.4 Merck & Co Revenue in Precision Cancer Medicine Business (2018-2024)
11.9.5 Merck & Co Recent Developments
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Precision Cancer Medicine Introduction
11.10.4 Takeda Revenue in Precision Cancer Medicine Business (2018-2024)
11.10.5 Takeda Recent Developments
11.11 Merck KGaA
11.11.1 Merck KGaA Company Details
11.11.2 Merck KGaA Business Overview
11.11.3 Merck KGaA Precision Cancer Medicine Introduction
11.11.4 Merck KGaA Revenue in Precision Cancer Medicine Business (2018-2024)
11.11.5 Merck KGaA Recent Developments
11.12 Seagen
11.12.1 Seagen Company Details
11.12.2 Seagen Business Overview
11.12.3 Seagen Precision Cancer Medicine Introduction
11.12.4 Seagen Revenue in Precision Cancer Medicine Business (2018-2024)
11.12.5 Seagen Recent Developments
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Precision Cancer Medicine Introduction
11.13.4 Eli Lilly Revenue in Precision Cancer Medicine Business (2018-2024)
11.13.5 Eli Lilly Recent Developments
11.14 Ono Pharmaceutical
11.14.1 Ono Pharmaceutical Company Details
11.14.2 Ono Pharmaceutical Business Overview
11.14.3 Ono Pharmaceutical Precision Cancer Medicine Introduction
11.14.4 Ono Pharmaceutical Revenue in Precision Cancer Medicine Business (2018-2024)
11.14.5 Ono Pharmaceutical Recent Developments
11.15 Pfizer
11.15.1 Pfizer Company Details
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Precision Cancer Medicine Introduction
11.15.4 Pfizer Revenue in Precision Cancer Medicine Business (2018-2024)
11.15.5 Pfizer Recent Developments
11.16 GSK
11.16.1 GSK Company Details
11.16.2 GSK Business Overview
11.16.3 GSK Precision Cancer Medicine Introduction
11.16.4 GSK Revenue in Precision Cancer Medicine Business (2018-2024)
11.16.5 GSK Recent Developments
11.17 Exelixis
11.17.1 Exelixis Company Details
11.17.2 Exelixis Business Overview
11.17.3 Exelixis Precision Cancer Medicine Introduction
11.17.4 Exelixis Revenue in Precision Cancer Medicine Business (2018-2024)
11.17.5 Exelixis Recent Developments
11.18 Regeneron
11.18.1 Regeneron Company Details
11.18.2 Regeneron Business Overview
11.18.3 Regeneron Precision Cancer Medicine Introduction
11.18.4 Regeneron Revenue in Precision Cancer Medicine Business (2018-2024)
11.18.5 Regeneron Recent Developments
11.19 Innovent
11.19.1 Innovent Company Details
11.19.2 Innovent Business Overview
11.19.3 Innovent Precision Cancer Medicine Introduction
11.19.4 Innovent Revenue in Precision Cancer Medicine Business (2018-2024)
11.19.5 Innovent Recent Developments
11.20 Hengrui Medicine
11.20.1 Hengrui Medicine Company Details
11.20.2 Hengrui Medicine Business Overview
11.20.3 Hengrui Medicine Precision Cancer Medicine Introduction
11.20.4 Hengrui Medicine Revenue in Precision Cancer Medicine Business (2018-2024)
11.20.5 Hengrui Medicine Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Precision Cancer Medicine Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Cancer Immunotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Global Precision Cancer Medicine Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Precision Cancer Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Precision Cancer Medicine Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Precision Cancer Medicine Market Share by Region (2018-2024)
Table 8. Global Precision Cancer Medicine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Precision Cancer Medicine Market Share by Region (2024-2029)
Table 10. Precision Cancer Medicine Market Trends
Table 11. Precision Cancer Medicine Market Drivers
Table 12. Precision Cancer Medicine Market Challenges
Table 13. Precision Cancer Medicine Market Restraints
Table 14. Global Precision Cancer Medicine Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Precision Cancer Medicine Revenue Share by Players (2018-2024)
Table 16. Global Top Precision Cancer Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Medicine as of 2022)
Table 17. Global Precision Cancer Medicine Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Precision Cancer Medicine Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Precision Cancer Medicine, Headquarters and Area Served
Table 20. Global Key Players of Precision Cancer Medicine, Product and Application
Table 21. Global Key Players of Precision Cancer Medicine, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Precision Cancer Medicine Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Precision Cancer Medicine Revenue Market Share by Type (2018-2024)
Table 25. Global Precision Cancer Medicine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Precision Cancer Medicine Revenue Market Share by Type (2024-2029)
Table 27. Global Precision Cancer Medicine Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Precision Cancer Medicine Revenue Share by Application (2018-2024)
Table 29. Global Precision Cancer Medicine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Precision Cancer Medicine Revenue Share by Application (2024-2029)
Table 31. North America Precision Cancer Medicine Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Precision Cancer Medicine Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Precision Cancer Medicine Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Precision Cancer Medicine Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Precision Cancer Medicine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Precision Cancer Medicine Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Precision Cancer Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Precision Cancer Medicine Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Precision Cancer Medicine Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Precision Cancer Medicine Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Precision Cancer Medicine Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Precision Cancer Medicine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Precision Cancer Medicine Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Precision Cancer Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Precision Cancer Medicine Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Precision Cancer Medicine Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Precision Cancer Medicine Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Precision Cancer Medicine Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Precision Cancer Medicine Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Precision Cancer Medicine Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Precision Cancer Medicine Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Precision Cancer Medicine Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Precision Cancer Medicine Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Precision Cancer Medicine Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Precision Cancer Medicine Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Precision Cancer Medicine Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Precision Cancer Medicine Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Precision Cancer Medicine Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Precision Cancer Medicine Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Precision Cancer Medicine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Precision Cancer Medicine Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Precision Cancer Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 63. AbbVie Company Details
Table 64. AbbVie Business Overview
Table 65. AbbVie Precision Cancer Medicine Product
Table 66. AbbVie Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 67. AbbVie Recent Developments
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Precision Cancer Medicine Product
Table 71. Johnson & Johnson Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 72. Johnson & Johnson Recent Developments
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Precision Cancer Medicine Product
Table 76. Novartis Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 77. Novartis Recent Developments
Table 78. Gilead Sciences Company Details
Table 79. Gilead Sciences Business Overview
Table 80. Gilead Sciences Precision Cancer Medicine Product
Table 81. Gilead Sciences Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 82. Gilead Sciences Recent Developments
Table 83. Roche Company Details
Table 84. Roche Business Overview
Table 85. Roche Precision Cancer Medicine Product
Table 86. Roche Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 87. Roche Recent Developments
Table 88. Bristol-Myers Squibb Company Details
Table 89. Bristol-Myers Squibb Business Overview
Table 90. Bristol-Myers Squibb Precision Cancer Medicine Product
Table 91. Bristol-Myers Squibb Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 92. Bristol-Myers Squibb Recent Developments
Table 93. Amgen Company Details
Table 94. Amgen Business Overview
Table 95. Amgen Precision Cancer Medicine Product
Table 96. Amgen Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 97. Amgen Recent Developments
Table 98. AstraZeneca Company Details
Table 99. AstraZeneca Business Overview
Table 100. AstraZeneca Precision Cancer Medicine Product
Table 101. AstraZeneca Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 102. AstraZeneca Recent Developments
Table 103. Merck & Co Company Details
Table 104. Merck & Co Business Overview
Table 105. Merck & Co Precision Cancer Medicine Product
Table 106. Merck & Co Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 107. Merck & Co Recent Developments
Table 108. Takeda Company Details
Table 109. Takeda Business Overview
Table 110. Takeda Precision Cancer Medicine Product
Table 111. Takeda Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 112. Takeda Recent Developments
Table 113. Merck KGaA Company Details
Table 114. Merck KGaA Business Overview
Table 115. Merck KGaA Precision Cancer Medicine Product
Table 116. Merck KGaA Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 117. Merck KGaA Recent Developments
Table 118. Seagen Company Details
Table 119. Seagen Business Overview
Table 120. Seagen Precision Cancer Medicine Product
Table 121. Seagen Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 122. Seagen Recent Developments
Table 123. Eli Lilly Company Details
Table 124. Eli Lilly Business Overview
Table 125. Eli Lilly Precision Cancer Medicine Product
Table 126. Eli Lilly Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 127. Eli Lilly Recent Developments
Table 128. Ono Pharmaceutical Company Details
Table 129. Ono Pharmaceutical Business Overview
Table 130. Ono Pharmaceutical Precision Cancer Medicine Product
Table 131. Ono Pharmaceutical Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 132. Ono Pharmaceutical Recent Developments
Table 133. Pfizer Company Details
Table 134. Pfizer Business Overview
Table 135. Pfizer Precision Cancer Medicine Product
Table 136. Pfizer Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 137. Pfizer Recent Developments
Table 138. GSK Company Details
Table 139. GSK Business Overview
Table 140. GSK Precision Cancer Medicine Product
Table 141. GSK Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 142. GSK Recent Developments
Table 143. Exelixis Company Details
Table 144. Exelixis Business Overview
Table 145. Exelixis Precision Cancer Medicine Product
Table 146. Exelixis Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 147. Exelixis Recent Developments
Table 148. Regeneron Company Details
Table 149. Regeneron Business Overview
Table 150. Regeneron Precision Cancer Medicine Product
Table 151. Regeneron Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 152. Regeneron Recent Developments
Table 153. Innovent Company Details
Table 154. Innovent Business Overview
Table 155. Innovent Precision Cancer Medicine Product
Table 156. Innovent Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 157. Innovent Recent Developments
Table 158. Hengrui Medicine Company Details
Table 159. Hengrui Medicine Business Overview
Table 160. Hengrui Medicine Precision Cancer Medicine Product
Table 161. Hengrui Medicine Revenue in Precision Cancer Medicine Business (2018-2024) & (US$ Million)
Table 162. Hengrui Medicine Recent Developments
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Precision Cancer Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Precision Cancer Medicine Market Share by Type: 2022 VS 2029
Figure 3. Cancer Immunotherapy Features
Figure 4. Targeted Therapy Features
Figure 5. Global Precision Cancer Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Precision Cancer Medicine Market Share by Application: 2022 VS 2029
Figure 7. Lung Cancer Case Studies
Figure 8. Breast Cancer Case Studies
Figure 9. Prostate Cancer Case Studies
Figure 10. Blood-related Cancer Case Studies
Figure 11. Other Case Studies
Figure 12. Precision Cancer Medicine Report Years Considered
Figure 13. Global Precision Cancer Medicine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Precision Cancer Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Precision Cancer Medicine Market Share by Region: 2022 VS 2029
Figure 16. Global Precision Cancer Medicine Market Share by Players in 2022
Figure 17. Global Top Precision Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Medicine as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Precision Cancer Medicine Revenue in 2022
Figure 19. North America Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Precision Cancer Medicine Market Share by Type (2018-2029)
Figure 21. North America Precision Cancer Medicine Market Share by Application (2018-2029)
Figure 22. North America Precision Cancer Medicine Market Share by Country (2018-2029)
Figure 23. United States Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Precision Cancer Medicine Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Precision Cancer Medicine Market Share by Type (2018-2029)
Figure 27. Europe Precision Cancer Medicine Market Share by Application (2018-2029)
Figure 28. Europe Precision Cancer Medicine Market Share by Country (2018-2029)
Figure 29. Germany Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Precision Cancer Medicine Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Precision Cancer Medicine Market Share by Type (2018-2029)
Figure 37. China Precision Cancer Medicine Market Share by Application (2018-2029)
Figure 38. Asia Precision Cancer Medicine Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Precision Cancer Medicine Market Share by Type (2018-2029)
Figure 40. Asia Precision Cancer Medicine Market Share by Application (2018-2029)
Figure 41. Asia Precision Cancer Medicine Market Share by Region (2018-2029)
Figure 42. Japan Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Precision Cancer Medicine Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Precision Cancer Medicine Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Precision Cancer Medicine Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Precision Cancer Medicine Market Share by Country (2018-2029)
Figure 52. Brazil Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Precision Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. AbbVie Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 59. Johnson & Johnson Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 60. Novartis Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 61. Gilead Sciences Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 62. Roche Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 64. Amgen Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 65. AstraZeneca Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 66. Merck & Co Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 67. Takeda Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 68. Merck KGaA Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 69. Seagen Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 70. Eli Lilly Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 71. Ono Pharmaceutical Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 72. Pfizer Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 73. GSK Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 74. Exelixis Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 75. Regeneron Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 76. Innovent Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 77. Hengrui Medicine Revenue Growth Rate in Precision Cancer Medicine Business (2018-2024)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed